Omnicare (OCR) Reports In-Line Q2 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
JPMorgan Downgrades Omnicare (OCR) to Neutral
July 24, 2015 3:40 PM EDTJPMorgan downgraded Omnicare (NYSE: OCR) from Overweight to Neutral with a price target of $98.00 (from $90.00).
For an analyst ratings summary and ratings history on Omnicare click here. For more ratings news on Omnicare click here.
Shares of Omnicare closed at $95.28 yesterday.
... More